Region: Global

This is an archive page containing all the publications filed under Region: Global

Want to search through the full database?

Grey literature from 2015

Hepatitis C Medicines: Technology and Market Landscape

Analytical Tool from 2010

Financing Contraceptives: A New Funding Environment

Analytical Tool from 2012

A Forecasting Guide For New and Underused Methods of Family Planning: What to Do When There Is No Trend Data?

Grey literature from 2013

DR-TB Drugs under the microscope: 3rd edition

Grey literature from 2012

DR-TB Drugs under the microscope: 2nd edition

Grey literature from 2014

Vaccinating Children Beyond the ‘Cold Chain’: Extending the heat stability of vaccines

Grey literature

Using National Resources to Finance Contraceptive Procurement: Policy Brief

Grey literature from 2013

Untangling the Web of Antiretroviral Price Reductions – 16th Edition, 2013

Grey literature from 2012

Untangling the Web of Antiretroviral Price Reductions – 15th Edition, 2012

Grey literature from 2011

Untangling the Web of Antiretroviral Price Reductions – 14th Edition, 2011

Peer-reviewed article from 2010

Innovative health service delivery models in low and middle income countries – what can we learn from the private sector?

Other published literature from 2010

A Value for Money Perspective Applied to Global Health Initiative Market Shaping Activities

Peer-reviewed article from 2015

It’s all about women: creating healthy, functional markets to address the unmet global need for contraception

Peer-reviewed article from 2014

Role of vaccine manufacturers in developing countries towards global health care by providing quality vaccines at affordable prices

Peer-reviewed article from 2006

Rethinking and reinventing Michael Porter’s five forces model

Peer-reviewed article from 2012

Reduced price on rotavirus vaccines: enough to facilitate access where most needed?

Peer-reviewed article from 2012

Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up

Grey literature from 2014

Solutions to improve access to medicines and biomedical innovation through EU trade and R&D policy

Peer-reviewed article from 2014

Applying lessons learned from the USAID family planning graduation experience to the GAVI graduation process

Grey literature from 2010

Private Sector Engagement in Sexual and Reproductive Health and Maternal and Neonatal Health: A Review of the Evidence

Grey literature from 2011

DR-TB Drugs under the microscope: 1st Edition

Analytical Tool from 2015

Scaling up life-saving commodities for women, children, and newborns: An Advocacy Toolkit

Peer-reviewed article from 2014

New Dialogue for the Way Forward in Maternal Health: Addressing Market Inefficiencies

Grey literature from 2015

Why UNITAID Matters for People Living with HIV/AIDS, TB and Malaria

Peer-reviewed article from 2011

A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries

Analytical Tool from 2012

Value for Money in LLIN Specifications Guidance: Ensuring highest value for money in LLIN procurement by balancing cost with end-user and program benefits

Peer-reviewed article from 2008

Demand Forecasting For Essential Medical Technologies

Other published literature from 2014

Towards the Standardization of Total Market Approach Indicators for Male Condoms

Peer-reviewed article from 2011

An integrative model for social marketing

Grey literature from 2014

A Review of the Sutezolid (PNU-100480) Patent Landscape

Grey literature from 2014

A Review of the SQ-109 Patent Landscape

Grey literature from 2014

A Review of the PA-824 Patent Landscape

Grey literature from 2014

A Review of the Delamanid Patent Landscape

Grey literature from 2014

A Review of the Bedaquiline Patent Landscape

Grey literature from 2014

A Review of the AZD5847 Patent Landscape

Grey literature from 2012

The Quality of Reproductive Health Medicines Programme: Key milestones and the road ahead for expanding access to affordable, quality-assured medicine and support

Grey literature from 2010

Procuring Contraceptives: Options for Countries

Grey literature from 2008

Procurement and Pricing of New Vaccines for Developing Countries

Grey literature from 2008

Financing Medical Innovation Through Alternative Mechanisms

Grey literature from 2012

Policy Brief: ACT Demand Forecast, 2012-2013

Grey literature from 2011

Market shaping: access to low and sustainable vaccine prices

Other published literature from 2011

Pneumococcal Advance Market Commitment: Lessons Learnt on Disease and Design Choices and Processes

Analytical Tool from 2015

Accelovate Maternal Health Drug Business Assessments User Guide

Other published literature from 2014

Business Case: Investing in Production of High-Quality Oxytocin for Low-Resource Settings

Other published literature from 2014

Business Case: Investing in Production of High-Quality Misoprostol for Low-Resource Settings

Other published literature from 2014

Business Case: Investing in Production of High-Quality Magnesium Sulfate for Low-Resource Settings

Other published literature from 2016

Qualitative Research for Social Marketing: One Organization’s Journey to Improved Consumer Insight

Analytical Tool from 2017

Pathways of Change: How DMPA-SC Introduction May Impact a National Family Planning Program

Other published literature from 2013

The Advance Market Commitment for Pneumococcal Vaccines: Process and Design Evaluation

Grey literature from 2012

Demand Forecast for Artemisinin-based Combination Therapies (ACTs) in 2012-2013 Q3-2012 Report

Grey literature from 2012

Demand Forecast for Artemisinin-based Combination Therapies (ACTs) in 2012-2013 Q2-2012 Report

Grey literature from 2012

Demand Forecast for Artemisinin-based Combination Therapies (ACTs) in 2012-2013 Q1-2012 Report

Grey literature from 2013

ARV Market Report: The State of the Antiretroviral Drug Market in Low- and Middle-Income Countries, November 2013

Grey literature from 2016

Policy Brief: Global Malaria Diagnostic and Artemisinin Treatment Commodities Demand Forecast 2015 – 2018

Grey literature from 2016

New MEASURE Evaluation Resources to Increase Access to Family Planning

Analytical Tool from 2016

Planning Guide for a Total Market Approach to Increase Access to Family Planning: Toolkit and Glossary

Grey literature from 2010

Assessing Policies and Practices That Affect Contraceptive Financing and Procurement

Analytical Tool from 2016

Planning Guide for a Total Market Approach to Increase Access to Family Planning Module 1: Landscape Assessment

Grey literature from 2011

Assessing demand for depo-subQ in Uniject: A five-country modeling exercise

Peer-reviewed article from 2011

An Analysis of How the GAVI Alliance and Low- and Middle-Income Countries Can Share Costs of New Vaccines

Other published literature from 2006

Advance Market Commitments for Vaccines Against Neglected Diseases: Estimating Costs and Effectiveness

Peer-reviewed article from 2011

Access to essential medicines for sexual and reproductive health care: The role of pharmaceutical industry and international regulation

Grey literature from 2012

Synthesis Report: UNFPA Global Programme to Enhance Reproductive Health Commodity Security Mid-Term Review Final draft (version 2)

Analytical Tool from 2004

Country Commodity Manager, Manual to Accompany A Computer Program for Management and Forecasting of Reproductive Health Commodity Needs

Peer-reviewed article from 2013

Methods for implementing a medicine outlet survey: lessons from the anti-malarial market

Grey literature from 2013

Monitoring supply and demand for antimalarials and RDTs: an update on ACTwatch

Other published literature from 2014

Market Shaping for Family Planning: An analysis of current activities and future opportunities to improve the effectiveness of family planning markets

Other published literature from 2014

Healthy Markets for Global Health: A Market Shaping Primer

Other published literature from 2011

Drugs and Vaccines for Developing Countries

Grey literature from 2011

Diagnostic market analysis: HIV simple/rapid, enzyme immunoassay (EIA) and supplemental tests: available data and implications for future funding

Grey literature from 2014

Ready, Set, Slow down: New and promising DR-TB drugs are grabbing headlines but not reaching patients: MSF on the policies underpinning the deadly DR-TB treatment gap

Grey literature from 2010

Differential Pricing for Pharmaceuticals: Review of current knowledge, new findings and ideas for action

Grey literature from 2008

Designing a Global Financing and Procurement Mechanism for Reproductive Health Supplies

Grey literature from 2016

Global Malaria Diagnostic and Artemisinin Treatment Commodities Demand Forecast: 2015-2018 Policy Brief

Grey literature from 2012

HIV, Tuberculosis and Malaria Medicines Landscape: Progress Report on Emerging Issues and Potential Opportunities to Improve Access

Grey literature from 2013

Malaria Medicines Landscape 2013

Grey literature from 2014

Malaria Diagnostics Technology and Market Landscape – 2nd Edition

Grey literature from 2014

Malaria Vector Control Commodities Landscape – 2nd edition

Grey literature from 2015

Malaria Diagnostics Landscape Update

Grey literature from 2015

Malaria Medicines Landscape 2015

Grey literature from 2016

Malaria Diagnostics Technology and Market Landscape: 3rd Edition

Grey literature from 2014

Tuberculosis Medicines Technology and Market Landscape 2014

Grey literature from 2015

Tuberculosis Diagnostics Technology and Market Landscape – 4th Edition

Grey literature from 2015

Tuberculosis Diagnostics Market in Select High-Burden Countries Current Market and Future Opportunities for Novel Diagnostics

Grey literature from 2015

Hepatitis C Medicines Technology and Market Landscape – Update

Peer-reviewed article from 2011

The ACTWATCH project: methods to describe anti-malarial markets in seven countries

Grey literature from 2014

HIV Medicines Technology and Market Landscape – 1st Edition

Grey literature from 2014

HIV Preventives Technology and Market Landscape – 2nd Edition

Peer-reviewed article from 2014

Implementing Total Market Approaches: Family Planning and Beyond

Grey literature from 2008

Contraceptive Security Ready Lessons II: Fostering Public-Private Collaboration for Improved Access

Grey literature from 2015

Landscape for HIV rapid diagnostic tests for HIV self-testing

Grey literature from 2017

Applying a Total Market Approach to DMPA-SC

Grey literature from 2016

Increasing Access to Essential Maternal Health Supplies: A scoping of market-based activities, gaps and opportunities

Grey literature from 2016

Global Contraceptive Commodity Gap Analysis Summary

Grey literature from 2005

RH COMMODITY SECURITY: ADEQUACY OF THE INTERNATIONAL ARCHITECTURE FOR FINANCE AND SUPPLY

Grey literature from 2013

Shaping the Market

Analytical Tool from 2016

Summary of August 2016 CSP Contraceptive Implant Demand Forecast

Analytical Tool from 2016

Summary of August 2015 CSP Contraceptive Implant Demand Forecast

Grey literature from 2016

Family Planning Market Report – August 2016

Grey literature from 2015

Family Planning Market Report – May 2015